Deacetyllanatoside C en es it fr

Deacetyllanatoside C Brand names, Deacetyllanatoside C Analogs

Deacetyllanatoside C Brand Names Mixture

  • No information avaliable

Deacetyllanatoside C Chemical_Formula

C24H28ClN5O3

Deacetyllanatoside C RX_link

No information avaliable

Deacetyllanatoside C fda sheet

Deacetyllanatoside C msds (material safety sheet)

Deacetyllanatoside_C MSDS

Deacetyllanatoside C Synthesis Reference

No information avaliable

Deacetyllanatoside C Molecular Weight

469.964 g/mol

Deacetyllanatoside C Melting Point

204.5 oC

Deacetyllanatoside C H2O Solubility

3000 mg/L

Deacetyllanatoside C State

Solid

Deacetyllanatoside C LogP

-0.39

Deacetyllanatoside C Dosage Forms

Capsule (sustained-release); Liquid; Solution; Suppository; Syrup; Tablet; Tablet (extended-release)

Deacetyllanatoside C Indication

Used for treating vertigo, motion sickness, and nausea associated with pregnancy.

Deacetyllanatoside C Pharmacology

Dimenhydrinate is an antiemetics drug combination that contains diphenhydramine and theophylline. It is not effective in the treatment of nausea associated with cancer chemotherapy. Dimenhydrinate directly inhibits the stimulation of certain nerves in the brain and inner ear to suppress nausea, vomiting, dizziness, and vertigo.

Deacetyllanatoside C Absorption

Well absorbed after oral administration.

Deacetyllanatoside C side effects and Toxicity

Symptoms of overdose include delerium and hallucinations.

Deacetyllanatoside C Patient Information

No information avaliable

Deacetyllanatoside C Organisms Affected

Humans and other mammals